| 09/12/24 | 07:00:07 | 9 Dec 2024 | | PRTC Presents LYT-200 Phase 1b Data in AML at ASH | RNS |
| 27/11/24 | 17:31:00 | 27 Nov 2024 | | Holding(s) in Company | RNS |
| 27/11/24 | 17:30:00 | 27 Nov 2024 | | Holding(s) in Company | RNS |
| 20/11/24 | 12:05:00 | 20 Nov 2024 | | PRTC's Seaport Adds Microsoft and J&J Exec to BOD | RNS |
| 05/11/24 | 12:05:00 | 5 Nov 2024 | | PRTC's Seaport Adds Biotech Finance Exec as CFO | RNS |
| 01/11/24 | 07:00:02 | 1 Nov 2024 | | Total Voting Rights | RNS |
| 31/10/24 | 17:00:01 | 31 Oct 2024 | | Director/PDMR Shareholding | RNS |
| 30/10/24 | 11:00:00 | 30 Oct 2024 | | PRTC to Present at UBS and Jefferies Conferences | RNS |
| 21/10/24 | 07:00:04 | 21 Oct 2024 | | PRTC's Seaport Closes $225M Series B Financing | RNS |
| 09/10/24 | 07:00:06 | 9 Oct 2024 | | PRTC's IPF Patient Research & Ph 2b On Track YE24 | RNS |
| 01/10/24 | 12:00:01 | 1 Oct 2024 | | PRTC to Give 3 Presentations at CHEST 2024 Meeting | RNS |
| 27/09/24 | 07:00:08 | 27 Sept 2024 | | KarXT/Cobenfy Approved by FDA; PRTC Receives $29M | RNS |
| 06/09/24 | 18:13:08 | 6 Sept 2024 | | Holding(s) in Company | RNS |
| 06/09/24 | 07:00:09 | 6 Sept 2024 | | PRTC's Vor Shares New AML Data Validating Approach | RNS |
| 28/08/24 | 07:01:00 | 28 Aug 2024 | | Half-year Report | RNS |
| 28/08/24 | 07:00:04 | 28 Aug 2024 | | Results of AGM on 13 June 2024 – Update Statement | RNS |
| 22/08/24 | 07:00:12 | 22 Aug 2024 | | PRTC Adds Industry Leader to Board of Directors | RNS |
| 21/08/24 | 07:00:08 | 21 Aug 2024 | | Notice of Results | RNS |
| 13/08/24 | 12:05:00 | 13 Aug 2024 | | PRTC's Seaport Appoints Global Pharma Exec to BOD | RNS |
| 23/07/24 | 12:05:00 | 23 Jul 2024 | | PRTC'S Vedanta Expands Leadership Team | RNS |
| 01/07/24 | 17:00:00 | 1 Jul 2024 | | Holding(s) in Company | RNS |
| 27/06/24 | 17:01:00 | 27 Jun 2024 | | PDMR Notification RSU Vesting | RNS |
| 27/06/24 | 17:00:00 | 27 Jun 2024 | | Director/PDMR Shareholding | RNS |
| 24/06/24 | 17:00:00 | 24 Jun 2024 | | Completion of Tender Offer & Total Voting Rights | RNS |
| 24/06/24 | 07:00:07 | 24 Jun 2024 | | Result of Tender Offer | RNS |
| 20/06/24 | 07:00:10 | 20 Jun 2024 | | Director Declaration | RNS |
| 18/06/24 | 12:05:00 | 18 Jun 2024 | | PRTC's Seaport Appoints Seasoned Execs to Team | RNS |
| 13/06/24 | 17:42:24 | 13 Jun 2024 | | Result of AGM | RNS |
| 07/06/24 | 17:30:01 | 7 Jun 2024 | | Holding(s) in Company | RNS |
| 06/06/24 | 17:34:24 | 6 Jun 2024 | | Result of Meeting | RNS |
| 04/06/24 | 07:00:09 | 4 Jun 2024 | | Additional Disclosure Re: Tender Offer | RNS |
| 03/06/24 | 07:00:05 | 3 Jun 2024 | | Total Voting Rights | RNS |
| 29/05/24 | 13:04:46 | 29 May 2024 | | PRTC's Akili Enters Into Merger Agreement | RNS |
| 23/05/24 | 12:00:00 | 23 May 2024 | | PRTC to Present at Jefferies Healthcare Conference | RNS |
| 21/05/24 | 12:05:00 | 21 May 2024 | | PRTC's Vedanta Begins Phase 3 of VE303 in C. diff | RNS |
| 20/05/24 | 07:00:08 | 20 May 2024 | | Tender Offer | RNS |
| 09/05/24 | 12:05:00 | 9 May 2024 | | PRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data | RNS |
| 07/05/24 | 12:05:00 | 7 May 2024 | | PRTC's Seaport Announces Board/Team Appointments | RNS |
| 01/05/24 | 07:00:10 | 1 May 2024 | | Total Voting Rights | RNS |
| 25/04/24 | 07:00:11 | 25 Apr 2024 | | Final Results | RNS |
| 18/04/24 | 07:00:13 | 18 Apr 2024 | | Notice of Results | RNS |
| 16/04/24 | 12:00:00 | 16 Apr 2024 | | PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024 | RNS |
| 11/04/24 | 12:00:00 | 11 Apr 2024 | | FDA Grants PRTC's LYT-200 Fast Track Designation | RNS |
| 09/04/24 | 07:00:12 | 9 Apr 2024 | | PRTC Launches Seaport w/ $100M; Leadership Changes | RNS |
| 19/03/24 | 07:00:09 | 19 Mar 2024 | | $100M Tender Offer | RNS |
| 18/03/24 | 13:32:34 | 18 Mar 2024 | | $14B Acquisition of PRTC’s Karuna by BMS Completed | RNS |
| 13/03/24 | 11:00:00 | 13 Mar 2024 | | FDA Grants PRTC's LYT-200 Orphan Drug Designation | RNS |
| 06/03/24 | 07:00:11 | 6 Mar 2024 | | PDMR Notification RSU Vesting | RNS |
| 27/02/24 | 12:00:00 | 27 Feb 2024 | | PRTC to Present at Cowen and Leerink Conferences | RNS |
| 27/02/24 | 07:00:10 | 27 Feb 2024 | | PRTC: Akili Positive Ph3 & Japan PMDA Submission | RNS |
